Keywords: Endocrine, Diabetes
Motivation: Diabetes Mellitus causes systemic changes in lipids of multiple organs. Previous studies have shown that receptor for advanced glycation end products (RAGE) and its tail binding partner diaphanous 1 (Diaph1) are key mediators of metabolic changes in T1D mice.
Goal(s): To use 1H-MRS and CSE-MRI to investigate the metabolic effects of the RAGE-DIAPH1 interaction antagonist, RAGE229, in T1D murine hearts and hind limb.
Approach: 18 mice were divided into 3 cohorts (Rage229/+db, RegDiet/+db, RegDiet/-db) and scanned using 1H-MRS and CSE-MRI.
Results: Inhibition of RAGE-DIAPH1 interaction by RAGE229 leads to significant reduction in triglyceride levels in hearts and hind limb of T1D mice.
Impact: The results of this study set the stage for further testing of RAGE229 as potential therapeutic adjuncts in alleviating metabolic dysfunction in T1D.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords